Bryan K Holcomb
Overview
Explore the profile of Bryan K Holcomb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
46
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dolejs S, Penning A, Guzman M, Fajardo A, Holcomb B, Robb B, et al.
J Gastrointest Surg
. 2018 Nov;
23(9):1867-1873.
PMID: 30411309
Background: Colovesical fistula (CVF) is an uncommon complication of diverticulitis. Substantial heterogeneity exists in the perioperative management of this condition. We seek to evaluate the role of bladder leak testing,...
2.
Dolejs S, Guzman M, Fajardo A, Holcomb B, Robb B, Waters J
J Gastrointest Surg
. 2018 Mar;
22(8):1404-1411.
PMID: 29569006
Background: Sigmoid volvulus is an uncommon cause of bowel obstruction that is historically associated with high morbidity and mortality. The objective of this study was to evaluate contemporary management of...
3.
Dolejs S, Guzman M, Fajardo A, Robb B, Holcomb B, Zarzaur B, et al.
J Gastrointest Surg
. 2016 Nov;
21(2):372-379.
PMID: 27896654
Background: Bowel preparation in elderly patients is associated with physiologic derangements that may result in postoperative complications. The aim of this study is to determine the impact of bowel preparation...
4.
Holcomb B, Yip-Schneider M, Waters J, Beane J, Crooks P, Schmidt C
J Gastrointest Surg
. 2012 May;
16(7):1333-40.
PMID: 22618517
Introduction: Gemcitabine is standard treatment for pancreatic cancer but has limited clinical benefit due to chemoresistance. Nuclear factor-kappaB (NF-κB) can promote chemoresistance and is therefore an attractive therapeutic target. We...